Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.
Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.
Azafaros aims at developing new therapeutic agents for the treatment of rare metabolic disorders.
Phosphoenix is a neurotechnology company.
Avidicure is pioneering an entirely new dual agonistic, multifunctional and avidity engineered antibody modality.
Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.
Tiga TX develops an IgA therapeutic monoclonal antibody platform for the treatment of solid tumors.
Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.
Therapeutics for obesity and obesity-related conditions.
Brenig Therapeutics develops therapies for neurodegenerative disorders.
CatalYm is a biotechnology company developing innovative immunotherapies for cancer patients.
FundaMental Pharma is a neuroscience company with a portfolio at the preclinical stage.
Artica Therapeutics specializes in biotechnological research and development for medical devices, pharmaceutical processes, and food.
Tessellate BIO is a biotechnology business in the preclinical stage that focuses on advanced Synthetic Lethality techniques.
Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.
Complement Therapeutics operates as a preclinical stage company.
Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors.
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies.
Fibrocor Therapeutics focuses on developing disease modifying therapeutics in fibrosis.
Escalier Biosciences BV is a privately held biopharmaceutical company.
Cristal Therapeutics is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies.
Lanthio Pharma is focused on the research and development of therapeutic lantipeptide drugs for serious diseases.
Dezima Pharma develops protein-based compounds for treatment of cardiovascular disease related to dyslipidemia.
BioGeneration Ventures has invested in 47 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioGeneration Ventures's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 12 different industry categories.
Among tracked funding rounds, CatalYm received $150.0M in a Series D round. BioGeneration Ventures's total known invested capital is $2.2B.
BioGeneration Ventures's average investment size is $58.5M across its portfolio of 47 companies.
Recent BioGeneration Ventures portfolio additions include TargED Biopharmaceuticals, Confo Therapeutics, Azafaros, Phosphoenix, Avidicure. These companies were founded in 2020 or later.